Swiss pharmaceutical supply chain technology company SkyCell has raised $57 million in a funding round led by Catalyst. With a remarkable compound growth of over 55% in the last three years, SkyCell intends to utilize the funds to expand its global presence. Led by CEO Richard Ettl, the company focuses on optimizing pharmaceutical supply chains by manufacturing temperature-controlled, door-to-door container solutions. SkyCell's proprietary software combines simulation and operational data, providing real-time oversight of shipments worldwide, and its automated approval capability significantly reduces quality approval time, expediting the delivery of sensitive drugs globally.